Anti-HER2 treatment in metastatic breast cancer: trastuzumab and beyond
Anti-HER2 treatment in metastatic breast cancer: trastuzumab and beyond
Results of seven year intraoperative radiation therapy trial
Endocrine management of breast cancer and advanced breast cancer
Non-drug treatments to help alleviate symptoms of treatment-induced menopause
15-year follow-up on radiotherapy treatment after surgery for ductal carcinoma in situ
Need for updated breast cancer guidelines and screening programs
FLIMS workshop and management of triple negative breast cancer
Debate on breast cancer screening contributing to drop in mortality
Triple negative advanced breast cancer treatment with PARP inhibitors
Highlights from EBCC 8 and looking to EBCC 9
ECCO and cancer care in Europe
Managing the toxicity of aromatase inhibitors